Phase Ib FIERCE Study Assesses Trifluridine/Tipiracil With Radiation in Rectal Cancer

◆ TRIAL DATA

A phase Ib study to assess the safety of neoadjuvant trifluridine/tipiracil combined with concurrent radiation in patients with resectable stage II/III rectal cancer. (Clinical Colorectal Cancer)